Filter Results :

Your search for Immune returned 87 reports

Sort by


Global Autoimmune Partnering 2010-2017: Deal trends, players and financials

01 Nov 2017  |  Published by:  CurrentPartnering
Global Autoimmune Partnering 2010 to 2017 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.-Trends in Autoimmune partnering deals-Financial deal terms for headline, upfront and royalty by stage of development-Au...

$ 2,995.00

Read More

ImmuneXcite Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Oct 2017  |  Published by:  GlobalData
SummaryImmuneXcite Inc (ImmuneXcite) is a biopharmaceutical company that develops immune-activating anti-tumor biotherapeutics for the treatment of cancer. The company develops monoclonal antibodies by employing its mAbXcite, an immunotherapy platform technology that targets cancer cells for destruc...

$ 250.00

Read More

AC Immune SA (ACIU) - Medical Equipment - Deals and Alliances Profile

25 Oct 2017  |  Published by:  GlobalData
SummaryAC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The company...

$ 250.00

Read More

AC Immune SA (ACIU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Oct 2017  |  Published by:  GlobalData
SummaryAC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The company...

$ 250.00

Read More

Globeimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Oct 2017  |  Published by:  GlobalData
SummaryGlobeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company offers products for infectious disease and oncology. Its oncology products include GI-4000, GI-6207 and GI-6301. Globeimmune's infectiou...

$ 250.00

Read More

Immune Pharmaceuticals Inc (IMNP) - Medical Equipment - Deals and Alliances Profile

17 Oct 2017  |  Published by:  GlobalData
SummaryImmune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative coli...

$ 250.00

Read More

Immune Pharmaceuticals Inc (IMNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Oct 2017  |  Published by:  GlobalData
SummaryImmune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative coli...

$ 250.00

Read More

Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

03 Oct 2017  |  Published by:  GBI Research
SummaryThe renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertensio...

$ 6,995.00

Read More

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

01 Oct 2017  |  Published by:  GlobalData
Summary“Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Auto-Immune Diseases Diagnostic Tests currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products at var...

$ 4,000.00

Read More

Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs

01 Oct 2017  |  Published by:  GBI Research
SummaryThe ophthalmologic therapy area encompasses a wide range of disorders affecting the eye and its supporting structures. These include glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic macular edema (DME) and dry eye syndrome (DES). The therapy area is charac...

$ 6,995.00

Read More

AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review

13 Sep 2017  |  Published by:  GlobalData
AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and t...

$ 125.00

Read More

Global Autoimmune Treatment Market Size and Forecast to 2021

07 Sep 2017  |  Published by:  9Dimen Research
Autoimmune Treatment Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Stat...

$ 1,990.00

Read More

Global Autoimmune Treatment Market Report and Forecast to 2021

07 Sep 2017  |  Published by:  9Dimen Research
Autoimmune Treatment Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Stat...

$ 3,200.00

Read More

Neurimmune Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Aug 2017  |  Published by:  GlobalData
SummaryNeurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a fo...

$ 250.00

Read More

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Aug 2017  |  Published by:  GlobalData
SummaryNovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and kap...

$ 250.00

Read More
Total 87 records.